Results 61 to 70 of about 46,054 (219)

Clinical Trials With Pragmatic Elements: A Review of Use Cases and Real‐World Data Utilization

Clinical Pharmacology &Therapeutics, EarlyView.
Clinical trials with pragmatic elements can capture diverse patient populations, enable efficient follow‐up, and reflect routine clinical practices; yet there is limited understanding of their design features, characteristics, and use of real‐world data (RWD). Based on a targeted search of PubMed/EMBASE (Jan‐2016 to Jul‐2024), a review was conducted to
Le Su, Lei Chen, Seema Betigeri, Nancy Dreyer, Helga Gardarsdottir, Rachele Hendricks‐Sturrup, Mehmet Burcu   +6 more
wiley   +1 more source

A new approach to planning in vitro and in vivo experiments for cardiovascular stents. (2) Planning of experiments [PDF]

, 2000
Copyright @ 2000 Pacini Editore SpAWithin our overall project to improve the design of stents in terms of reduced rates of re-stenosis, there are three main methods, namely computer simulation and in vitro and in vivo experiments.
Atherton, MA, Collins, MW, Doorly, DJ, Sigwart, U   +3 more
core  

Introduction. Carotid endarterectomy versus carotid stenting. A never-ending story [PDF]

, 2018
L'articolo discute le controversie relative all'accettazione in pratica clinica dello stentig ...
de Donato, Gianmarco, Setacci, Carlo, Sterpetti, Antonio   +2 more
core   +1 more source

Impact of New Portal Reconstruction Strategy on Portal Vein Growth and Outcomes in Living‐Donor Liver Transplantation for Small Children With Biliary Atresia

Journal of Hepato-Biliary-Pancreatic Sciences, EarlyView.
ABSTRACT Background/Purpose We evaluated the outcomes of a new reconstruction method that we adopted in 2017 for small children with biliary atresia, involving aggressive resection of the sclerotic portal vein (PV), larger anastomotic orifice, and proactive vein graft interposition.
Hikaru Aoki, Eri Ogawa, Takashi Ito, Elena Yukie Uebayashi, Shinya Okumura, Yuki Masano, Tatsuya Okamoto, Hironori Haga, Hideaki Okajima, Etsuro Hatano   +9 more
wiley   +1 more source

Management of Subglottic Stenosis With the “Maddern Procedure”: Long Term Follow‐Up Outcomes

The Laryngoscope, EarlyView.
The Maddern procedure is an effective and durable option for patients with idiopathic subglottic stenosis. Five‐year recurrence‐free rate is 83%, and the mMRC dyspnea scale improves from 2.7 (SD 0.73) to 0.52 (SD 0.85). ABSTRACT Objective Full‐thickness resection and skin grafting of the laryngotracheal junction, the “Maddern Procedure,” can be used to
Emilie A. C. Dronkers, Gemma M. Clunie, Aphrodite Iacovidou, S. A. Reza Nouraei, Chadwan Al Yaghchi, Guri S. Sandhu   +5 more
wiley   +1 more source

Pharmacologic approaches against advanced glycation end products (ages) in diabetic cardiovascular disease [PDF]

, 2015
Advanced Glycation End-Products (AGEs) are signaling proteins associated to several vascular and neurological complications in diabetic and non-diabetic patients.
Avtaar Singh, Sanjeet Singh, Chello, Massimo, DI DOMENICO, Fabio, Nappi, Francesco, Nenna, Antonio, Spadaccio, Cristiano, Sutherland, Fraser W   +6 more
core   +2 more sources

Mucosal Grafts and Flaps in Draf IIb and Draf III: A Systematic Review and Meta‐analysis

Otolaryngology–Head and Neck Surgery, EarlyView.
Abstract Objective To evaluate the impact of mucosal grafts and flaps on neo‐ostium patency and clinical outcomes in patients undergoing Draf IIb or III frontal sinus drill‐out procedures. Data Sources A systematic search was conducted across PubMed, Medline, Cochrane Library, Scopus, and Web of Science databases in accordance with Preferred Reporting ...
Alexander Lein, David T. Liu, Birgit Knerer, Christian A. Mueller, Nicole Rotter, Erich Vyskocil, Archana Jaiswal, Faris F. Brkic, Rajiv Bhalla   +8 more
wiley   +1 more source

In-Stent Restenosis in the Drug-Eluting Stent Era

Journal of the American College of Cardiology, 2010
The introduction of the drug-eluting stent (DES) proved to be an important step forward in reducing rates of restenosis and target lesion revascularization after percutaneous coronary intervention. However, the rapid implementation of DES in standard practice and expansion of the indications for percutaneous coronary intervention to high-risk patients ...
George Dangas, Roxana Mehran, Bimmer E. Claessen, Adriano Caixeta, Elias Sanidas, Gary S. Mintz   +5 more
openaire   +3 more sources

Treatment of atherosclerotic renovascular hypertension: review of observational studies and a meta-analysis of randomized clinical trials. [PDF]

, 2015
open9Atherosclerotic renal artery stenosis can cause ischaemic nephropathy and arterial hypertension. We herein review the observational and randomized clinical trials (RCTs) comparing medical and endovascular treatment for control of hypertension and ...
Caielli, P, Calò, Frigo, Anna Chiara, Maiolino, G, Miotto, Diego, Pengo, Mf, Rossi, Gianpaolo, Rossitto, G, Seccia, Teresa Maria   +8 more
core   +1 more source

Impact of Immunosuppressive Drugs on Patients With Percutaneous Left Atrial Appendage Occlusion

Journal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Introduction Percutaneous left atrial appendage closure (LAAC) reduces the risk of thromboembolic stroke in patients with non‐valvular atrial fibrillation who cannot tolerate long‐term oral anticoagulation. However, outcomes after LAAC in patients requiring chronic immunosuppressive therapy (IMS) remain unknown. This study aimed to investigate
Daisuke Togashi, Christopher R. Ellis, Zachary T. Yoneda, Jackon G. Gregory, Shunsuke Uetake, Salah H. Alahwany, Michael T. Baker, Arvindh N. Kanagasundram   +7 more
wiley   +1 more source